Clinical applications of ketamine: a literature review
DOI:
https://doi.org/10.12775/QS.2024.18.53759Keywords
ketamine, anesthesia, critical care, psychiatry, depression, painAbstract
Ketamine, initially recognized for its anesthetic capabilities, has emerged as a multifaceted pharmacological intervention with applications extending beyond the surgical setting. This literature review explores the diverse clinical applications of ketamine, delving into its well-established role in anesthesiology and its burgeoning potential in the psychiatric domain. The review discusses ketamine's mechanism of action, emphasizing its unique profile as an NMDA receptor antagonist. Its rapid-acting antidepressant and anti-suicidal effects are highlighted, along with its efficacy in treating conditions like treatment-resistant depression and post-traumatic stress disorder. Additionally, the review examines ketamine's utility in pain management, particularly for acute and chronic pain syndromes. This comprehensive assessment underscores ketamine's evolving role as a valuable tool in both anesthesiology and psychiatry.
Materials and methods
A comprehensive review of the scientific literature was conducted by thoroughly searching the PubMed database to closely examine the most recent findings on the various clinical applications of ketamine. The search was carefully restricted to only include articles published within the last 10 years, with a focus on those that were indexed in PubMed, written in English, and categorized as high-quality meta-analyses, original research studies, clinical trials, or comprehensive review articles. In order to ensure the most relevant and reliable information was gathered, case reports and non-English language articles were excluded from consideration. The key terms used for searching the database encompassed the broad range of ketamine's clinical uses, including "ketamine," "anesthesia," "critical care," "psychiatry," "depression," and "pain."
References
Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016 Jul;37(7):865-72. doi: 10.1038/aps.2016.5. Epub 2016 Mar 28. PMID: 27018176; PMCID: PMC4933765
Lengvenyte, A., Strumila, R., Olié, E., & Courtet, P. (2022). Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how? European Neuropsychopharmacology, 57, 88-104. https://doi.org/10.1016/j.euroneuro.2022.02.004
WHO Model Lists of Essential Medicines https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists [access: 7.07.2024]
DEA Ketamine https://www.dea.gov/factsheets/ketamine [access 7.07.2024]
Das, J. (2020). Repurposing of Drugs–The Ketamine Story. Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.0c01193
Walsh, Z., Mollaahmetoğlu, Ö M., Rootman, J M., Golsof, S., Keeler, J L., Marsh, B., Nutt, D., & Morgan, P G. (2021, December 23). Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. Cambridge University Press, 8(1). https://doi.org/10.1192/bjo.2021.1061
Kurdi, M. S., Theerth, K. A., & Deva, R. S. (2014). Ketamine: Current applications in anesthesia, pain, and critical care. Anesthesia, Essays and Researches, 8(3), 283-290. https://doi.org/10.4103/0259-1162.143110
Robinson, B., Gu, Q., & Kanungo, J. (2021). Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels. Chemical Research in Toxicology, 34(5), 1198–1207. doi:10.1021/acs.chemrestox.0c00411
De Kock M, Loix S, Lavand'homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther. 2013 Jun;19(6):403-10. doi: 10.1111/cns.12104. Epub 2013 Apr 10. PMID: 23574634; PMCID: PMC6493703.
Goddard, K B., Sampson, C., Bedy, S., Ghadban, R., & Stilley, J A. (2021, March 31). Effect of Ketamine on Cardiovascular Function During Procedural Sedation of Adults. Cureus, Inc.. https://doi.org/10.7759/cureus.14228
Gärtner, M., Weigand, A., Meiering, M. S., Weigner, D., Carstens, L., Keicher, C., Hertrampf, R., Beckmann, C., Mennes, M., Wunder, A., & Grimm, S. (2023). Region- and time- specific effects of ketamine on cerebral blood flow: A randomized controlled trial. Neuropsychopharmacology, 48(12), 1735-1741. https://doi.org/10.1038/s41386-023-01605-4
Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care 2014;21:163–173.
Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on intracranial pressure in nontraumatic neurological illness. J Crit Care 2014;29:1096–1106.
Zanza, C., Piccolella, F., Racca, F., Romenskaya, T., Longhitano, Y., Franceschi, F., Savioli, G., Bertozzi, G., Simone, S D., Cipolloni, L., & Russa, R L. (2022, March 17). Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity. Multidisciplinary Digital Publishing Institute, 10(3), 566-566. https://doi.org/10.3390/healthcare10030566
Heinz P, Geelhoed GC, Wee C, Pascoe EM. Is atropine needed with ketamine sedation? A prospective, randomised, double blind study. Emerg Med J. 2006 Mar;23(3):206-9. doi: 10.1136/emj.2005.028969. PMID: 16498158; PMCID: PMC2464444.
Pruskowski, K A., Harbourt, K., Pajoumand, M., Chui, S J., & Reynolds, H N. (2017, November 29). Impact of Ketamine Use on Adjunctive Analgesic and Sedative Medications in Critically Ill Trauma Patients. Wiley-Blackwell, 37(12), 1537-1544. https://doi.org/10.1002/phar.2042
Plunkett, A., Turabi, A., & Wilkinson, I. (2012, May 1). Battlefield analgesia: a brief review of current trends and concepts in the treatment of pain in US military casualties from the conflicts in Iraq and Afghanistan. Future Medicine, 2(3), 231-238. https://doi.org/10.2217/pmt.12.18
Brinck, E., Tiippana, E., Heesen, M., Bell, R F., Straube, S., Moore, R A., & Kontinen, V. (2018, December 20). Perioperative intravenous ketamine for acute postoperative pain in adults. Elsevier BV. https://doi.org/10.1002/14651858.cd012033.pub4
Hublet, S., Galland, M., Navez, J., Loi, P., Closset, J., Forget, P., & Lafère, P. (2022). Opioid-free versus opioid-based anesthesia in pancreatic surgery. BMC Anesthesiology, 22. https://doi.org/10.1186/s12871-021-01551-y
Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study. Pain Med 2008;9(8):1173–201
Lii, T. R., & Singh, V. (2023). Ketamine for Complex Regional Pain Syndrome: A Narrative Review Highlighting Dosing Practices and Treatment Response. Anesthesiology Clinics, 41(2), 357. https://doi.org/10.1016/j.anclin.2023.03.005
Mazzeffi, M A., Johnson, K M., & Paciullo, C. (2015, January 1). Ketamine in adult cardiac surgery and the cardiac surgery Intensive Care Unit: An evidence-based clinical review. Medknow, 18(2), 202-202. https://doi.org/10.4103/0971-9784.154478
Sakrikar, D G. (2018, April 14). Ketamine- The wonder drug in Status Asthmaticus. , 6(4). https://doi.org/10.18535/jmscr/v6i4.90
Alkhachroum, A., Der-Nigoghossian, C. A., Mathews, E., Massad, N., Letchinger, R., Doyle, K., Chiu, T., Kromm, J., Rubinos, C., Velazquez, A., Roh, D., Agarwal, S., Park, S., Connolly, E. S., & Claassen, J. (2020). Ketamine to treat super-refractory status epilepticus. Neurology, 95(16), e2286. https://doi.org/10.1212/WNL.0000000000010611
Han, Y., Li, P., Miao, M., Tao, Y., Kang, X., & Zhang, J. (2022). S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: A randomized controlled trial. BMC Anesthesiology, 22. https://doi.org/10.1186/s12871-022-01588-7
J. Wang, Z. Xu, Z. Feng, R. Ma, X. Zhang Impact of ketamine on pain management in cesarean section: a systematic review and meta-analysis Pain Physician, 23 (2) (2020), pp. 135-148
Haliloglu, M., Ozdemir, M., Uzture, N., Cenksoy, P. O., & Bakan, N. (2015). Perioperative low-dose ketamine improves postoperative analgesia following Cesarean delivery with general anesthesia. The Journal of Maternal-Fetal & Neonatal Medicine, 29(6), 962–966. doi:10.3109/14767058.2015.1027190
Li, S., Zhou, W., Li, P., & Lin, R. (2024). Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis. Journal of Affective Disorders, 351, 720-728. https://doi.org/10.1016/j.jad.2024.01.202
Schenberg, E E. (2018, July 5). Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development. Frontiers Media, 9. https://doi.org/10.3389/fphar.2018.00733
Bahji, A., & Vazquez, G. H. (2020). Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. Journal of Affective Disorders, 278, 542. https://doi.org/10.1016/j.jad.2020.09.071
Hurst, K. T., Vogeley, A., Greenstein, D. K., Durland, L., Makel, S., Wang, P. R., Yavi, M., Zarate, C. A., & Ballard, E. D. (2024). Long-term follow-up of participants in ketamine clinical trials for mood disorders. Journal of Affective Disorders, 357, 134-137. https://doi.org/10.1016/j.jad.2024.04.062
Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. J. A. (2018). Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology. doi:10.1016/j.neuropharm.2018.01.017
Schenberg, E E. (2018, July 5). Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development. Frontiers Media, 9. https://doi.org/10.3389/fphar.2018.00733
Feder, A., Rutter, S. B., Schiller, D., & Charney, D. S. (2019). The emergence of ketamine as a novel treatment for posttraumatic stress disorder. Advances in Pharmacology, 89, 261-286. https://doi.org/10.1016/bs.apha.2020.05.004
Ateş, İ., Aydın, M E., Çelik, E C., Gözeler, M S., & Ahıskalıoğlu, A. (2020, December 9). Perioperative Intravenous Low-Dose Ketamine Infusion to Minimize Pain for Septorhinoplasty: A Prospective, Randomized, Double-Blind Study. SAGE Publishing, 100(4), 254-259. https://doi.org/10.1177/0145561320974860
Gorlin, A., Rosenfeld, D M., & Ramakrishna, H. (2016, January 1). Intravenous sub-anesthetic ketamine for perioperative analgesia. Medknow, 32(2), 160-160. https://doi.org/10.4103/0970-9185.182085
Myers, F. A.; Bluth, M. H.; Cheung, W. W. Ketamine: a cause of urinary tract dysfunction. Clin. Lab. Med. 2016, 36, 721-744.
Tang, J., Wu, Q., Qi, C., Xie, A., Liu, J., Sun, Y., Yuan, T., Chen, W., Liu, T., Hao, W., Shao, X., & Liao, Y. (2024). Widespread reductions in cortical thickness following ketamine abuse. Journal of Psychiatry & Neuroscience : JPN, 49(3), E182. https://doi.org/10.1503/jpn.230111
Short B, Dong V, Gálvez V, Vulovic V, Martin D, Bayes AJ, Zarate CA, Murrough JW, McLoughlin DM, Riva-Posse P, Schoevers R, Fraguas R, Glue P, Fam J, McShane R, Loo CK. Development of the Ketamine Side Effect Tool (KSET). J Affect Disord. 2020 Apr 1;266:615-620. doi: 10.1016/j.jad.2020.01.120. Epub 2020 Jan 25. PMID: 32056935; PMCID: PMC7693479.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Agata Kaptur, Dawid Dziedziński, Dawid Łoś, Aleksandra Nowak, Anita Janus, Oliwia Kwaśniewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 132
Number of citations: 0
